These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 22414003

  • 1. How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products.
    Fontaine MJ, Mills AM, Weiss S, Hong WJ, Viele M, Goodnough LT.
    Transfusion; 2012 Oct; 52(10):2081-5. PubMed ID: 22414003
    [No Abstract] [Full Text] [Related]

  • 2. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.
    Karafin MS, Blagg L, Tobian AA, King KE, Ness PM, Savage WJ.
    Transfusion; 2012 Oct; 52(10):2087-93. PubMed ID: 22339320
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy.
    Josephson CD, Mullis NC, Van Demark C, Hillyer CD.
    Transfusion; 2004 Jun; 44(6):805-8. PubMed ID: 15157243
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
    Scholl S, Klink A, Mügge LO, Schilling K, Höffken K, Sayer HG.
    Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
    [Abstract] [Full Text] [Related]

  • 8. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD, Castillejo MI, Grima K, Hillyer CD.
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [Abstract] [Full Text] [Related]

  • 9. Apheresis platelet transfusions: does ABO matter?
    Herman JH, King KE.
    Transfusion; 2004 Jun; 44(6):802-4. PubMed ID: 15157242
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immune hemolytic anemia caused by antibodies of the ABO system following ABO-incompatible kidney transplantation. Gm allotyping of the immune antibody].
    Bein G, Poschmann A, Rob P.
    Beitr Infusionsther; 1988 Jun; 21():251-4. PubMed ID: 2462986
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hemolysis in ABO-incompatible liver transplantation.
    Angstadt J, Jarrell B, Maddrey W, Munoz S, Yang SL, Moritz M, Carabasi A.
    Transplant Proc; 1987 Dec; 19(6):4595-7. PubMed ID: 3321627
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.